Abstract PS5-05-14: Real-world outcomes of trastuzumab deruxtecan (T-DXd) in patients with HER2+ metastatic breast cancer: Turkish oncology group multicenter study
Year: 2026
Type: conference-abstract
Source: Clinical Cancer Research
Authors: T. Sahin, F. Kemik, H. Muglu, S. Biter, S. Tunbekici, A. Oruc, A. Guren, K. Kaban, M. Aykan, B. Koylu, O. Ekinci, I. Deliktas Onur, A. Kalem, O. Altunok, M. Seyyar, B. Guney, O. Akdogan, M. Yazici, N. Majidova, E. Esin, D. Cabuk, O. Yazici, R. Gursu, M. Yilmaz, H. Yesil Cinkir, O. Ates, E. Celik, N. Karadurmus, N. Mandel, I. Bayoglu, M. Araz, E. Goker, E. Bayram, D. Erdem, F. Selcukbiricik, G. Basaran, A. Sezer, A. Bilici, S. Gunduz, D. Guven, S. Aksoy
Institutions: Hacettepe University, Koç University, Istanbul Medipol University, Cukurova University, Ege University, Necmettin Erbakan University, Marmara University, Amerikan Hastanesi, Sağlık Bilimleri Üniversitesi, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Gaziantep University, Bakırköy Dr.Sadi Konuk Eğitim ve Araştırma Hastanesi, Gaziantep Şehir Hastanesi, İstanbul Eğitim ve Araştırma Hastanesi, Gazi University, Kocaeli Üniversitesi, Bayındır Hastanesi, Acıbadem University, Başkent University
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7129509155
Cites:
Cited by:
Related to: